VACCINEX, INC. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Form of Inducement Letter Agreement, by and between the Company and each purchaser identified on the signature pages thereto, dated as of September 17, 2024 (Filed With SEC on September 19, 2024)
- Form of Amendment and Restatement of the Vaccinex, Inc. Common Stock Purchase Warrant (November 2023, as amended March 2024) (Filed With SEC on May 15, 2024)
- Form of Amendment and Restatement of the Vaccinex, Inc. Common Stock Purchase Warrant (February 2024, as amended March 2024) (Filed With SEC on May 15, 2024)
- Form of Amendment and Restatement of the Vaccinex, Inc. Common Stock Purchase Warrant (October 2023, as amended March 2024) (Filed With SEC on May 15, 2024)
- Form of Placement Agent Agreement (Filed With SEC on September 26, 2023)
- Open Market Sale AgreementSM by and between the Company and Jefferies, LLC, dated March 27, 2020 (Filed With SEC on March 27, 2020)
- May 15, 2014 Amendment to the Vaccinex, Inc. 2011 Employee Equity Plan (Filed With SEC on August 8, 2018)
- Vaccinex, Inc. 2001 Employee Equity Plan (as amended May 25, 2006) (Filed With SEC on August 8, 2018)
- Agreement, dated March 16, 2018, by and among the Company, VX3 (DE) LP, VX3 Inc., and each of the other parties on the signature pages thereto (Filed With SEC on July 9, 2018)
- Consent and Amendment, dated June 12, 2018, by and among VX3, Inc., FCMI Parent Co., the Company and VX3 (DE) LP (Filed With SEC on July 9, 2018)
- Consent and Amendment, dated May 15, 2018, by and among VX3 Inc., FCMI Parent Co., the Company and VX3 (DE) LP (Filed With SEC on July 9, 2018)
- Consent and Amendment, dated February 28, 2018, by and among VX3 Inc., FCMI Parent Co., the Company and VX3 (DE) LP (Filed With SEC on July 9, 2018)
- GPEx Derived Cell Line Sale Agreement, dated January 13, 2010, by and between the Company and Catalent Pharma Solutions, LLC (Filed With SEC on July 9, 2018)
- 2011 Employee Equity Plan (Filed With SEC on July 9, 2018)
- 2001 Employee Equity Plan (Filed With SEC on July 9, 2018)
